Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study-Reference-Cited by-同舟云学术

Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study

Published:2021-08 Issue: Volume:Volume 13 Page:6115-6122
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Li Qing^ORCID,Ma Jingjing^ORCID,Ma Yan,Lin Zhiguang,Kang Hui,Chen Bobin

Publisher

Informa UK Limited

Subject

Oncology

Reference30 articles.

1. Advances in the treatment of newly diagnosed primary central nervous system lymphomas

2. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

3. Primary brain tumours in adults

4. Have treatment protocols for primary CNS lymphoma advanced in the past 10 years

5. The role of surgery in intracranial PCNSL

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study;Cancers;2023-09-15

2. Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?;Blood Reviews;2023-09

3. Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma;Journal of Oncology Pharmacy Practice;2023-05-17

4. A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma;Cancers;2023-02-25

5. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis;Journal of Neuro-Oncology;2022-11-30